Gene therapy for cardiovascular disease

Dishart, K.L., Work, L.M. , Denby, L. and Baker, A.H. (2003) Gene therapy for cardiovascular disease. Journal of Biomedicine and Biotechnology, 2003(2), pp. 138-148. (doi:10.1155/S1110724303209086)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1155/S1110724303209086

Abstract

The last decade has seen substantial advances in the development of gene therapy strategies and vector technology for the treatment of a diverse number of diseases, with a view to translating the successes observed in animal models into the clinic. Perhaps the overwhelming drive for the increase in vascular gene transfer studies is the current lack of successful long-term pharmacological treatments for complex cardiovascular diseases. The increase in cardiovascular disease to epidemic proportions has also led many to conclude that drug therapy may have reached a plateau in its efficacy and that gene therapy may represent a realistic solution to a long-term problem. Here, we discuss gene delivery approaches and target diseases.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Baker, Professor Andrew and Denby, Dr Laura and Work, Dr Lorraine
Authors: Dishart, K.L., Work, L.M., Denby, L., and Baker, A.H.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of Biomedicine and Biotechnology
ISSN:1110-7243
ISSN (Online):1110-7251

University Staff: Request a correction | Enlighten Editors: Update this record